Supernus Pharmaceuticals (SUPN) PT Raised to $63 at Mizuho Securities
Tweet Send to a Friend
Mizuho Securities analyst Irina Koffler raised the price target on Supernus Pharmaceuticals (NASDAQ: SUPN) to $63.00 (from $61.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
